IL17A and myeloid sarcoma: It has so far been shown that in the active phase of MS, the levels of interleukin 2 (IL-2), IL-3, IL-4, IL-6, IL-13, IL-17, IL-21, IL-22 and IL-33, among others, are elevated, compared to a control group of healthy individuals and patients in remission.